Hainan Drinda New Energy Technology (002865) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
7 Oct, 2026Executive summary
H1 2026 revenue was RMB3,150.8m, down 13.8% YoY; net loss attributable to owners narrowed 4.0% to RMB253.0m amid persistent solar-sector oversupply and weak pricing.
Focus remained on N-type cell technology, cost reduction, overseas sales and capacity partnerships, alongside new investments in space photovoltaics and commercial aerospace.
Financial highlights
Revenue fell to RMB3,150.8m from RMB3,655.6m, mainly as overseas sales declined amid international trade friction, partly offset by higher mainland sales.
Gross profit rose to RMB78.9m from RMB0.9m, supported by higher average selling prices and production-process optimization.
Total period loss was RMB256.3m versus RMB263.7m; loss attributable to owners was RMB253.0m versus RMB263.7m.
Other income increased to RMB137.9m from RMB42.7m, mainly due to higher additional input-VAT deductions; other gains turned to a RMB176.0m loss, including FX and fair-value losses.
Operating cash flow was an outflow of RMB54.7m versus an inflow of RMB1,031.9m in H1 2025; cash and equivalents were RMB2,642.1m at June 30, 2026.
Outlook and guidance
Management cited long-term sector potential from global energy transition, AI computing infrastructure, energy storage and new application markets; no specific earnings guidance was stated.
The planned Oman 5GW cell facility faced delays amid trade and tariff uncertainty and rising Middle East geopolitical risk; alternative partners and revised project options are under review.
The Turkey cell facility had begun production and was ramping up, supporting the intended local-production, local-delivery model.
Latest events from Hainan Drinda New Energy Technology
- N-type shipments surged, but price pressure drove a sharp swing to loss.002865
H1 2024 - Revenue contracted sharply as PERC shutdowns and impairment accompanied a swing to loss.002865
H2 2024 - Overseas growth and IPO funding contrasted with falling revenue and a wider H1 loss.002865
H1 2025 - Revenue fell, losses deepened, and overseas expansion accelerated amid sector pressure.002865
H2 2025